New Alzheimer’s Drug: Verubecestat
Verubecestat Promises Alzheimer’s Hope On November 2, 2016, Science Translational Medicine published an important study about a promising new drug for Alzheimer’s Disease. The drug name is Verubecestat and it is produced by Merck Research Laboratories. The drug is now in Phase 3 trials, and the company expects results to be available in late 2017. …
Continue reading “New Alzheimer’s Drug: Verubecestat”
Read More